C83.90
Non-follicular (diffuse) lymphoma, unspecified, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Non-follicular (diffuse) lymphoma is a type of cancer that originates in the lymphatic system, which is part of the body's immune system. This form of lymphoma is characterized by the widespread, diffuse growth of malignant lymphocytes, unlike follicular lymphomas which tend to involve groups of lymph nodes. When classified as unspecified, it means that the exact site of the lymphoma within the body has not been determined. ICD-10 code C83.90 encompasses these cases, providing a way for healthcare professionals to document and categorize this condition.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal lymphocyte growth Exposure to certain chemicals or radiation Weakened immune system due to infections or immunosuppressive treatments Family history of lymphatic or other related cancers Chronic infections like hepatitis C or certain bacterial infections
Key Symptoms: Painless swelling of lymph nodes, often in the neck, armpits, or groin Unexplained weight loss Persistent fever without an apparent infection Night sweats Fatigue or general weakness Itching skin Shortness of breath or chest pain if lymph nodes enlarge near the lungs or chest
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical examination, imaging studies, and tissue biopsies. The steps may include: - Physical examination focusing on lymph nodes and other organs - Imaging tests such as PET scans, CT scans, or MRI to identify affected areas - Lymph node biopsy, where a sample is taken for microscopic examination to confirm malignancy - Blood tests to assess overall health and organ function - Additional tests like bone marrow biopsy or molecular studies may be performed to determine the lymphoma subtype and extent Since the condition is described as unspecified, precise localization within the body may not be determined at the time of diagnosis.
Treatment Protocols: Treatment options depend on the stage of the lymphoma, patient health, and other factors. Common approaches include: - Chemotherapy to destroy cancer cells - Radiation therapy targeting specific enlarged lymph nodes or regions - Targeted therapy aimed at specific molecules involved in lymphoma growth - Immunotherapy to boost the body's natural defenses against cancer - Stem cell or bone marrow transplant in certain cases Early diagnosis and tailored treatment plans significantly influence outcomes. Multidisciplinary teams of healthcare providers typically coordinate care to optimize each patient’s journey.
Clinical Advice & FAQs
Billing Guidance
Is C83.90 a billable ICD-10 code?
Yes, C83.90 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.90?
Clinical documentation must specify the nature of Non-follicular (diffuse) lymphoma, unspecified, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
